BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van den Anker J, Reed MD, Allegaert K, Kearns GL. Developmental Changes in Pharmacokinetics and Pharmacodynamics. The Journal of Clinical Pharmacology 2018;58:S10-25. [DOI: 10.1002/jcph.1284] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Das B, Tk Baidya A, Mathew AT, Kumar Yadav A, Kumar R. Structural modification aimed for improving solubility of lead compounds in early phase drug discovery. Bioorganic & Medicinal Chemistry 2022. [DOI: 10.1016/j.bmc.2022.116614] [Reference Citation Analysis]
2 Magliocco G, Rodieux F, Desmeules J, Samer CF, Daali Y. Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling. Pediatr Res 2020;87:441-9. [DOI: 10.1038/s41390-019-0609-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Favié LMA, Huitema ADR, van den Broek MPH, Rademaker CMA, de Haan TR, van Straaten HLM, Simons SHP, Rijken M, Nuytemans DHGM, Egberts TCG, Groenendaal F; PharmaCool study group*. Lidocaine as treatment for neonatal seizures: Evaluation of previously developed population pharmacokinetic models and dosing regimen. Br J Clin Pharmacol 2020;86:75-84. [PMID: 31663153 DOI: 10.1111/bcp.14136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Eerdekens M, Beuter C, Lefeber C, van den Anker J. The challenge of developing pain medications for children: therapeutic needs and future perspectives. J Pain Res 2019;12:1649-64. [PMID: 31213880 DOI: 10.2147/JPR.S195788] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
5 Raffaeli G, Pokorna P, Allegaert K, Mosca F, Cavallaro G, Wildschut ED, Tibboel D. Drug Disposition and Pharmacotherapy in Neonatal ECMO: From Fragmented Data to Integrated Knowledge. Front Pediatr 2019;7:360. [PMID: 31552205 DOI: 10.3389/fped.2019.00360] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
6 Elkomy MH, Alruwaili N, Elmowafy M, Shalaby K, Drover DR, Ramamoorthy C. Assessment of Ketamine Adult Anesthetic Doses in Pediatrics Using Pharmacokinetic Modeling and Simulations. Pharmacotherapy 2019;39:454-62. [PMID: 30825333 DOI: 10.1002/phar.2243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 van Donge T, Allegaert K, Pfister M, Smits A, van den Anker J. Creatinine Trends to Detect Ibuprofen-Related Maturational Adverse Drug Events in Neonatal Life: A Simulation Study for the ELBW Newborn. Front Pharmacol 2020;11:610294. [PMID: 33569003 DOI: 10.3389/fphar.2020.610294] [Reference Citation Analysis]
8 van Donge T, Welzel T, Atkinson A, van den Anker J, Pfister M. Age-Dependent Changes of Kidney Injury Biomarkers in Pediatrics. J Clin Pharmacol 2019;59 Suppl 1:S21-32. [PMID: 31502686 DOI: 10.1002/jcph.1487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Leitzen S, Dubrall D, Toni I, Stingl J, Schulz M, Schmid M, Neubert A, Sachs B. Analysis of the reporting of adverse drug reactions in children and adolescents in Germany in the time period from 2000 to 2019. PLoS One 2021;16:e0247446. [PMID: 33657139 DOI: 10.1371/journal.pone.0247446] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Polasek TM, Rostami-Hodjegan A, Yim DS, Jamei M, Lee H, Kimko H, Kim JK, Nguyen PTT, Darwich AS, Shin JG. What Does it Take to Make Model-Informed Precision Dosing Common Practice? Report from the 1st Asian Symposium on Precision Dosing. AAPS J 2019;21:17. [PMID: 30627939 DOI: 10.1208/s12248-018-0286-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
11 van Groen BD, van Duijn E, de Vries A, Mooij MG, Tibboel D, Vaes WHJ, de Wildt SN. Proof of Concept: First Pediatric [14 C]microtracer Study to Create Metabolite Profiles of Midazolam. Clin Pharmacol Ther 2020;108:1003-9. [PMID: 32386327 DOI: 10.1002/cpt.1884] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Meyers RS, Thackray J, Matson KL, McPherson C, Lubsch L, Hellinga RC, Hoff DS. Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List. J Pediatr Pharmacol Ther 2020;25:175-91. [PMID: 32265601 DOI: 10.5863/1551-6776-25.3.175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ayuso M, Buyssens L, Stroe M, Valenzuela A, Allegaert K, Smits A, Annaert P, Mulder A, Carpentier S, Van Ginneken C, Van Cruchten S. The Neonatal and Juvenile Pig in Pediatric Drug Discovery and Development. Pharmaceutics 2020;13:44. [PMID: 33396805 DOI: 10.3390/pharmaceutics13010044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Arrieta AC, Ang JY, Espinosa C, Fofanov O, Tøndel C, Chou MZ, De Anda CS, Kim JY, Li D, Sabato P, Sears PS, Bradley JS. Pharmacokinetics and Safety of Single-dose Tedizolid Phosphate in Children 2 to <12 Years of Age. Pediatr Infect Dis J 2021;40:317-23. [PMID: 33710976 DOI: 10.1097/INF.0000000000003030] [Reference Citation Analysis]
15 Reed MD, van den Anker J. Developmental Pharmacotherapy: The Interface Between Ontogeny and Drug Effect. J Clin Pharmacol 2018;58 Suppl 10:S7-9. [PMID: 30248194 DOI: 10.1002/jcph.1317] [Reference Citation Analysis]
16 Van den Eynde J, Manlhiot C, Van De Bruaene A, Diller GP, Frangi AF, Budts W, Kutty S. Medicine-Based Evidence in Congenital Heart Disease: How Artificial Intelligence Can Guide Treatment Decisions for Individual Patients. Front Cardiovasc Med 2021;8:798215. [PMID: 34926630 DOI: 10.3389/fcvm.2021.798215] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chaudhari BB, Sridhar P, Moorkoth S, Lewis LE, Mallayasamy S. Validation of an HPLC method for estimation of cefotaxime from dried blood spot: alternative to plasma-based PK evaluation in neonates. Bioanalysis 2021. [PMID: 34472377 DOI: 10.4155/bio-2021-0130] [Reference Citation Analysis]
18 Verscheijden LF, Koenderink JB, Johnson TN, de Wildt SN, Russel FG. Physiologically-based pharmacokinetic models for children: Starting to reach maturation? Pharmacology & Therapeutics 2020;211:107541. [DOI: 10.1016/j.pharmthera.2020.107541] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
19 Pathomthongtaweechai N, Muanprasat C. Potential Applications of Chitosan-Based Nanomaterials to Surpass the Gastrointestinal Physiological Obstacles and Enhance the Intestinal Drug Absorption. Pharmaceutics 2021;13:887. [PMID: 34203816 DOI: 10.3390/pharmaceutics13060887] [Reference Citation Analysis]
20 Monteiro FASG, Soares CN, Chaveiro LG, Cabral VA, Lima PMA. Survey of off-label prescribing in a university paediatric outpatient in Brazil. Trop Doct 2022;:494755211068644. [PMID: 35037806 DOI: 10.1177/00494755211068644] [Reference Citation Analysis]
21 Wang S, Liu R, Fu Y, Kao WJ. Release mechanisms and applications of drug delivery systems for extended-release. Expert Opin Drug Deliv 2020;17:1289-304. [PMID: 32619149 DOI: 10.1080/17425247.2020.1788541] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
22 Tsai PC, Wu YK, Hu JH, Li IC, Lin TW, Chen CC, Kuo CF. Preclinical Bioavailability, Tissue Distribution, and Protein Binding Studies of Erinacine A, a Bioactive Compound from Hericium erinaceus Mycelia Using Validated LC-MS/MS Method. Molecules 2021;26:4510. [PMID: 34361662 DOI: 10.3390/molecules26154510] [Reference Citation Analysis]
23 Corriol-Rohou S, Cheung SYA. Industry Perspective on Using MIDD for Pediatric Studies Requiring Integration of Ontogeny. J Clin Pharmacol 2019;59 Suppl 1:S112-9. [PMID: 31502694 DOI: 10.1002/jcph.1495] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 van der Perk MEM, Broer L, Yasui Y, Robison LL, Hudson MM, Laven JSE, van der Pal HJ, Tissing WJE, Versluys B, Bresters D, Kaspers GJL, de Vries ACH, Lambalk CB, Overbeek A, Loonen JJ, Beerendonk CCM, Byrne J, Berger C, Clemens E, Dirksen U, Falck Winther J, Fosså SD, Grabow D, Muraca M, Kaiser M, Kepák T, Kruseova J, Modan-Moses D, Spix C, Zolk O, Kaatsch P, Krijthe JH, Kremer LCM, Brooke RJ, Baedke JL, van Schaik RHN, van den Anker JN, Uitterlinden AG, Bos AME, van Leeuwen FE, van Dulmen-den Broeder E, van der Kooi ALF, van den Heuvel-Eibrink MM, On Behalf Of The PanCareLIFE Consortium. Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study. Cancers (Basel) 2021;13:4598. [PMID: 34572825 DOI: 10.3390/cancers13184598] [Reference Citation Analysis]
25 De Rose DU, Cairoli S, Dionisi M, Santisi A, Massenzi L, Goffredo BM, Dionisi-Vici C, Dotta A, Auriti C. Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug Administration in Neonates Using New Techniques: An Overview on the Pharmacokinetics and Pharmacodynamics in Neonatal Age. Int J Mol Sci 2020;21:E5898. [PMID: 32824472 DOI: 10.3390/ijms21165898] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
26 Schijvens AM, de Wildt SN, Schreuder MF. Pharmacokinetics in children with chronic kidney disease. Pediatr Nephrol 2020;35:1153-72. [PMID: 31375913 DOI: 10.1007/s00467-019-04304-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Kaneria NS, Tuleu C, Ernest T. Opportunities for enteral drug delivery for neonates, infants and toddlers: a critical exploration. Expert Opin Drug Deliv 2022. [PMID: 35404191 DOI: 10.1080/17425247.2022.2064449] [Reference Citation Analysis]
28 van den Anker JN. Pharmacological treatment of neonatal pain: are we ready for a paradigm shift? Comment on Br J Anaesth 2021; 126: e133-5. Br J Anaesth 2021;126:e135-6. [PMID: 33583578 DOI: 10.1016/j.bja.2021.01.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Allegaert K, van den Anker J. Ontogeny of Phase I Metabolism of Drugs. J Clin Pharmacol 2019;59 Suppl 1:S33-41. [PMID: 31502685 DOI: 10.1002/jcph.1483] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
30 Flint RB, Allegaert K. Target Drug Exposure Attainment in Children: How to Get from Better to Best. Paediatr Drugs 2020;22:445-7. [PMID: 32507957 DOI: 10.1007/s40272-020-00402-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Lin W, Chen Y, Unadkat JD, Zhang X, Wu D, Heimbach T. Applications, Challenges, and Outlook for PBPK Modeling and Simulation: A Regulatory, Industrial and Academic Perspective. Pharm Res 2022. [PMID: 35552967 DOI: 10.1007/s11095-022-03274-2] [Reference Citation Analysis]
32 Faisal M, Cawello W, Laeer S; LENA Consortium. Clinical Pharmacokinetics of Enalapril and Enalaprilat in Pediatric Patients-A Systematic Review. Front Pediatr 2021;9:611322. [PMID: 33643971 DOI: 10.3389/fped.2021.611322] [Reference Citation Analysis]
33 Smits A, Annaert P, Van Cruchten S, Allegaert K. A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates. Front Pharmacol 2020;11:587. [PMID: 32477113 DOI: 10.3389/fphar.2020.00587] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
34 Verscheijden LFM, van der Zanden TM, van Bussel LPM, de Hoop-Sommen M, Russel FGM, Johnson TN, de Wildt SN. Chloroquine Dosing Recommendations for Pediatric COVID-19 Supported by Modeling and Simulation. Clin Pharmacol Ther 2020;108:248-52. [PMID: 32320477 DOI: 10.1002/cpt.1864] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
35 Favié LMA, de Haan TR, Bijleveld YA, Rademaker CMA, Egberts TCG, Nuytemans DHGM, Mathôt RAA, Groenendaal F, Huitema ADR. Prediction of Drug Exposure in Critically Ill Encephalopathic Neonates Treated With Therapeutic Hypothermia Based on a Pooled Population Pharmacokinetic Analysis of Seven Drugs and Five Metabolites. Clin Pharmacol Ther 2020;108:1098-106. [PMID: 32463940 DOI: 10.1002/cpt.1917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
36 Park YA, Song YB, Yee J, Yoon HY, Gwak HS. Influence of CYP2C9 Genetic Polymorphisms on the Pharmacokinetics of Losartan and Its Active Metabolite E-3174: A Systematic Review and Meta-Analysis. J Pers Med 2021;11:617. [PMID: 34210056 DOI: 10.3390/jpm11070617] [Reference Citation Analysis]
37 van Donge T, Samiee-Zafarghandy S, Pfister M, Koch G, Kalani M, Bordbar A, van den Anker J. Methadone dosing strategies in preterm neonates can be simplified. Br J Clin Pharmacol 2019;85:1348-56. [PMID: 30805946 DOI: 10.1111/bcp.13906] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
38 Wang J, van den Anker JN, Burckart GJ. Progress in Drug Development-Pediatric Dose Selection: Workshop Summary. J Clin Pharmacol 2021;61 Suppl 1:S13-21. [PMID: 34185909 DOI: 10.1002/jcph.1828] [Reference Citation Analysis]
39 Li M, He Q, Yao L, Wang X, Tang Z, Zhu X, Lin HS, Xiang X. Simultaneous Quantification of Propylthiouracil and Its N-β-d Glucuronide by HPLC-MS/MS: Application to a Metabolic Study. Pharmaceuticals (Basel) 2021;14:1194. [PMID: 34832976 DOI: 10.3390/ph14111194] [Reference Citation Analysis]
40 van den Anker J, Allegaert K. Considerations for Drug Dosing in Premature Infants. J Clin Pharmacol 2021;61 Suppl 1:S141-51. [PMID: 34185893 DOI: 10.1002/jcph.1884] [Reference Citation Analysis]
41 Fairman K, Li M, Ning B, Lumen A. Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges. Biochem Pharmacol 2021;189:114468. [PMID: 33577889 DOI: 10.1016/j.bcp.2021.114468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Siafaka P, Ipekci E, Caglar EŞ, Ustundag Okur N, Buyukkayhan D. Current Status of Pediatric Formulations for Chronic and Acute Children' Diseases: Applications and Future Perspectives. Medeni Med J 2021;36:152-62. [PMID: 34239768 DOI: 10.5222/MMJ.2021.78476] [Reference Citation Analysis]
43 Bolislis WR, Corriol-Rohou S, Hill-Venning C, Hoogland H, Joos A, King D, Kitcatt V, Le Visage G, Kühler TC. Orphan Medicines for Pediatric Use: A Focus on the European Union. Clin Ther 2019;41:2630-42. [PMID: 31704041 DOI: 10.1016/j.clinthera.2019.10.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Song IK, Yi S, Lim HS, Lee JH, Kim EH, Cho JY, Kim MC, Kim JT, Kim HS. A Population Pharmacokinetic Model of Intravenous Dexmedetomidine for Mechanically Ventilated Children after Neurosurgery. J Clin Med 2019;8:E1563. [PMID: 31581476 DOI: 10.3390/jcm8101563] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
45 Crescioli G, Lombardi N, Vagnoli L, Bettiol A, Giunti L, Cetica V, Coniglio ML, Provenzano A, Giglio S, Bonaiuti R, Mugelli A, Aricò M, Messeri A, Vannacci A, Maggini V. STOP Pain Project—Opioid Response in Pediatric Cancer Patients and Gene Polymorphisms of Cytokine Pathways. Pharmaceutics 2022;14:619. [DOI: 10.3390/pharmaceutics14030619] [Reference Citation Analysis]
46 van Donge T, Evers K, Koch G, van den Anker J, Pfister M. Clinical Pharmacology and Pharmacometrics to Better Understand Physiological Changes During Pregnancy and Neonatal Life. Handb Exp Pharmacol 2020;261:325-37. [PMID: 30968215 DOI: 10.1007/164_2019_210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
47 Zhu H, Chang W, Zhou C, Xu C, Su W, Gao F, Tan X, Lu S. Chemicalome and metabolome profiling of Chai-Gui Decoction using an integrated strategy based on UHPLC-Q-TOF-MS/MS analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2021;1185:122979. [PMID: 34688199 DOI: 10.1016/j.jchromb.2021.122979] [Reference Citation Analysis]
48 Sibeko L, Johns T, Cordeiro LS. Traditional plant use during lactation and postpartum recovery: Infant development and maternal health roles. J Ethnopharmacol 2021;279:114377. [PMID: 34192598 DOI: 10.1016/j.jep.2021.114377] [Reference Citation Analysis]
49 Sibeko L, Johns T. Global survey of medicinal plants during lactation and postpartum recovery: Evolutionary perspectives and contemporary health implications. J Ethnopharmacol 2021;270:113812. [PMID: 33450288 DOI: 10.1016/j.jep.2021.113812] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
50 Turner MA, Hildebrand H, Fernandes RM, de Wildt SN, Mahler F, Hankard R, Leary R, Bonifazi F, Nobels P, Cheng K, Attar S, Rossi P, Rocchi F, Claverol J, Nafria B, Giaquinto C. The conect4children (c4c) Consortium: Potential for Improving European Clinical Research into Medicines for Children. Pharmaceut Med 2021;35:71-9. [PMID: 33539007 DOI: 10.1007/s40290-020-00373-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Streekstra EJ, Russel FGM, van de Steeg E, de Wildt SN. Application of proteomics to understand maturation of drug metabolizing enzymes and transporters for the optimization of pediatric drug therapy. Drug Discov Today Technol 2021;39:31-48. [PMID: 34906324 DOI: 10.1016/j.ddtec.2021.06.008] [Reference Citation Analysis]
52 van den Anker J. Paediatric extrapolation: the panacea for paediatric drug development? Br J Clin Pharmacol 2019;85:672-4. [PMID: 30536691 DOI: 10.1111/bcp.13836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
53 Allegaert K, van den Anker J. Dose-Related Adverse Drug Events in Neonates: Recognition and Assessment. J Clin Pharmacol 2021;61 Suppl 1:S152-60. [PMID: 34185907 DOI: 10.1002/jcph.1827] [Reference Citation Analysis]
54 Turner MA, Cheng K, de Wildt S, Hildebrand H, Attar S, Rossi P, Bonifazi D, Ceci A, Claverol J, Nafria B, Giaquinto C. European research networks to facilitate drug research in children. Br J Clin Pharmacol 2020. [PMID: 32893382 DOI: 10.1111/bcp.14545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
55 Zheng Y, Ye PP, Zhou Y, Wu SY, Liu XT, Du B, Tang BH, Kan M, Nie AQ, Yin R, Wang M, Hao GX, Song LL, Yang XM, Huang X, Su LQ, Wang WQ, van den Anker J, Zhao W. LPS-Induced Inflammation Affects Midazolam Clearance in Juvenile Mice in an Age-Dependent Manner. J Inflamm Res 2021;14:3697-706. [PMID: 34377007 DOI: 10.2147/JIR.S321492] [Reference Citation Analysis]
56 O'Brien F, Clapham D, Krysiak K, Batchelor H, Field P, Caivano G, Pertile M, Nunn A, Tuleu C. Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine. Int J Mol Sci 2019;20:E2688. [PMID: 31159216 DOI: 10.3390/ijms20112688] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
57 Van den Anker JN, McCune S, Annaert P, Baer GR, Mulugeta Y, Abdelrahman R, Wu K, Krudys KM, Fisher J, Slikker W, Chen C, Burckart GJ, Allegaert K. Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs. Pharmaceutics 2020;12:E685. [PMID: 32698409 DOI: 10.3390/pharmaceutics12070685] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
58 Dawwas GK, Hennessy S, Brensinger CM, Acton EK, Bilker WB, Chung S, Dublin S, Horn JR, Manis MM, Miano TA, Oslin DW, Pham Nguyen TP, Soprano SE, Wiebe DJ, Leonard CE. Signals of Muscle Relaxant Drug Interactions Associated with Unintentional Traumatic Injury: A Population-Based Screening Study. CNS Drugs. [DOI: 10.1007/s40263-022-00909-1] [Reference Citation Analysis]
59 Yoder R, Hulvershorn L, Ott C, Minshawi-Patterson N. Re: "Amantadine for Treatment of Disruptive Mood Dysregulation Disorder Symptoms" by Rice T et al. J Child Adolesc Psychopharmacol 2020;30:531-2. [PMID: 32392424 DOI: 10.1089/cap.2020.0022] [Reference Citation Analysis]
60 Mussap M, Loddo C, Fanni C, Fanos V. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics. Expert Rev Clin Pharmacol 2020;13:115-34. [PMID: 31958027 DOI: 10.1080/17512433.2020.1713750] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
61 Wollmer E, Ungell AL, Nicolas JM, Klein S. Review of paediatric gastrointestinal physiology relevant to the absorption of orally administered medicines. Adv Drug Deliv Rev 2021;:114084. [PMID: 34929252 DOI: 10.1016/j.addr.2021.114084] [Reference Citation Analysis]
62 Rodieux F, Piguet V, Desmeules J, Samer CF. Safety Issues of Pharmacological Acute Pain Treatment in Children. Clin Pharmacol Ther 2019;105:1130-8. [DOI: 10.1002/cpt.1358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
63 Favié LMA, Groenendaal F, van den Broek MPH, Rademaker CMA, de Haan TR, van Straaten HLM, Dijk PH, van Heijst A, Simons SHP, Dijkman KP, Rijken M, Zonnenberg IA, Cools F, Zecic A, van der Lee JH, Nuytemans DHGM, van Bel F, Egberts TCG, Huitema ADR; on behalf of the PharmaCool study group. Phenobarbital, Midazolam Pharmacokinetics, Effectiveness, and Drug-Drug Interaction in Asphyxiated Neonates Undergoing Therapeutic Hypothermia. Neonatology 2019;116:154-62. [PMID: 31256150 DOI: 10.1159/000499330] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
64 Ashley EA, Poespoprodjo JR. Treatment and prevention of malaria in children. Lancet Child Adolesc Health 2020;4:775-89. [PMID: 32946831 DOI: 10.1016/S2352-4642(20)30127-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
65 Chen XY, Han HF, He ZY, Xu XG. Immune Mechanism, Gene Module, and Molecular Subtype Identification of Astragalus Membranaceus in the Treatment of Dilated Cardiomyopathy: An Integrated Bioinformatics Study. Evid Based Complement Alternat Med 2021;2021:2252832. [PMID: 34567206 DOI: 10.1155/2021/2252832] [Reference Citation Analysis]
66 Liu XI, Momper JD, Rakhmanina NY, Green DJ, Burckart GJ, Cressey TR, Mirochnick M, Best BM, van den Anker JN, Dallmann A. Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir. Clin Pharmacokinet 2021;60:795-809. [PMID: 33527213 DOI: 10.1007/s40262-020-00977-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Allegaert K. A Critical Review on the Relevance of Paracetamol for Procedural Pain Management in Neonates. Front Pediatr 2020;8:89. [PMID: 32257982 DOI: 10.3389/fped.2020.00089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
68 Welzel T, Winskill C, Zhang N, Woerner A, Pfister M. Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials. Pediatr Rheumatol Online J 2021;19:46. [PMID: 33766063 DOI: 10.1186/s12969-021-00514-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
69 Yu M, Tu P, Dolios G, Dassanayake PS, Volk H, Newschaffer C, Fallin MD, Croen L, Lyall K, Schmidt R, Hertz-Piccioto I, Austin C, Arora M, Petrick LM. Tooth biomarkers to characterize the temporal dynamics of the fetal and early-life exposome. Environ Int 2021;157:106849. [PMID: 34482270 DOI: 10.1016/j.envint.2021.106849] [Reference Citation Analysis]
70 Zhou J, You X, Ke M, Ye L, Wu W, Huang P, Lin C. Dosage Adjustment for Ceftazidime in Pediatric Patients With Renal Impairment Using Physiologically Based Pharmacokinetic Modeling. J Pharm Sci 2021;110:1853-62. [PMID: 33556385 DOI: 10.1016/j.xphs.2021.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Masarwa R, Lefebvre C, Platt RW, Filion KB. General practitioner prescribing trends among pediatric patients in the United Kingdom: 1998-2018. Pharmacoepidemiol Drug Saf 2021. [PMID: 34708900 DOI: 10.1002/pds.5377] [Reference Citation Analysis]
72 Ramos SF, Alvarez NR, Dos Santos Alcântara T, Sanchez JM, da Costa Lima E, de Lyra Júnior DP. Methods for the detection of adverse drug reactions in hospitalized children: a systematic review. Expert Opin Drug Saf 2021;:1-12. [PMID: 33926346 DOI: 10.1080/14740338.2021.1924668] [Reference Citation Analysis]
73 van den Anker J, Allegaert K. Rational Use of Antibiotics in Neonates: Still in Search of Tailored Tools. Healthcare (Basel) 2019;7:E28. [PMID: 30781454 DOI: 10.3390/healthcare7010028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
74 Gijsen M, Vlasselaers D, Spriet I, Allegaert K. Pharmacokinetics of Antibiotics in Pediatric Intensive Care: Fostering Variability to Attain Precision Medicine. Antibiotics (Basel) 2021;10:1182. [PMID: 34680763 DOI: 10.3390/antibiotics10101182] [Reference Citation Analysis]
75 Smits A, Annaert P, Cavallaro G, De Cock PAJG, de Wildt SN, Kindblom JM, Lagler FB, Moreno C, Pokorna P, Schreuder MF, Standing JF, Turner MA, Vitiello B, Zhao W, Weingberg AM, Willmann R, van den Anker J, Allegaert K. Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper. Br J Clin Pharmacol 2021. [PMID: 34180088 DOI: 10.1111/bcp.14958] [Reference Citation Analysis]
76 Lenoir C, Rodieux F, Desmeules JA, Rollason V, Samer CF. Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review. Clin Pharmacokinet 2021;60:1537-55. [PMID: 34462878 DOI: 10.1007/s40262-021-01064-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Tahir M, Ali S, Zhang W, Lv B, Qiu W, Wang J. Aloperine: A Potent Modulator of Crucial Biological Mechanisms in Multiple Diseases. Biomedicines 2022;10:905. [DOI: 10.3390/biomedicines10040905] [Reference Citation Analysis]